#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Huntington's disease Palmoplantar pustulosis Chordoma Choroid melanoma Sickle cell disease Chronic lymphocytic leukaemia recurrent Thrombocytopenia Vascular calcification Pyruvate dehydrogenase complex deficiency Antithrombin III deficiency Neurofibroma Hereditary haemorrhagic telangiectasia Univentricular heart Hyperadrenocorticism Henoch-Schonlein purpura nephritis More trials…

Learn about Rare Diseases

Hepatic angiosarcoma – Life with Disease Primary immunodeficiency syndrome – Treatment Hereditary hypophosphataemic rickets – Life with Disease Pemphigus – Diagnostics Pulmonary sarcoidosis – Diagnostics KBG syndrome Hypereosinophilic syndrome Anaplastic thyroid cancer – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Indolent systemic mastocytosis More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Bms-986435 Tadalafil Specific Nucleic Acid Sna-Xfsb Rosnilimab Allopurinol Sodium Mercaptopurine Monohydrate Sacituzumab Govitecan Fazirsiran Tiemonium Methylsulphate Sodium Chloride Ph. Eur. Belinostat LY4170156 Letetresgene Autoleucel ALE.P02 Binimetinib Cisplatin GSK5733584 Dosulepin Hydrochloride Clindamycin Specific Nucleic Acid Sna-Her1 More therapies…

Learn about Your Condition

Urethral stenosis Naevus flammeus Coronary artery occlusion Ovarian granulosa cell tumour Endocarditis enterococcal Aortic valve stenosis Torticollis Primary hyperoxaluria H1N1 influenza Persistent depressive disorder Propionic acidaemia Oesophageal cancer metastatic Malignant lymphoid neoplasm Hepato-lenticular degeneration Cervical dysplasia More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Plasma cell myeloma

Study on the Effectiveness of Bortezomib, Melphalan, and Prednisone vs. Carfilzomib, Lenalidomide, and Dexamethasone in Older Adults with Newly Diagnosed Multiple Myeloma

Not recruiting

3 1 1 1
Investigated Drugs:
Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
+8

1 … 25 26 27

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Plasma cell myeloma

Study on the Effectiveness of Bortezomib, Melphalan, and Prednisone vs. Carfilzomib, Lenalidomide, and Dexamethasone in Older Adults with Newly Diagnosed Multiple Myeloma

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies